Investment House LLC’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $479K | Sell |
7,480
-500
| -6% | -$32.1K | 0.02% | 180 |
|
|
2025
Q1 | $506K | Hold |
7,980
| – | – | 0.03% | 175 |
|
|
2024
Q4 | $531K | Buy |
7,980
+345
| +5% | +$23K | 0.03% | 159 |
|
|
2024
Q3 | $533K | Hold |
7,635
| – | – | 0.03% | 168 |
|
|
2024
Q2 | $495K | Buy |
7,635
+450
| +6% | +$29.2K | 0.03% | 161 |
|
|
2024
Q1 | $465K | Buy |
7,185
+2,535
| +55% | +$164K | 0.03% | 163 |
|
|
2023
Q4 | $306K | Hold |
4,650
| – | – | 0.02% | 172 |
|
|
2023
Q3 | $265K | Sell |
4,650
-575
| -11% | -$32.8K | 0.02% | 168 |
|
|
2023
Q2 | $320K | Sell |
5,225
-75
| -1% | -$4.6K | 0.02% | 166 |
|
|
2023
Q1 | $333K | Hold |
5,300
| – | – | 0.03% | 162 |
|
|
2022
Q4 | $337K | Sell |
5,300
-100
| -2% | -$6.35K | 0.03% | 147 |
|
|
2022
Q3 | $318K | Sell |
5,400
-200
| -4% | -$11.8K | 0.03% | 152 |
|
|
2022
Q2 | $323K | Sell |
5,600
-600
| -10% | -$34.6K | 0.03% | 142 |
|
|
2022
Q1 | $385K | Sell |
6,200
-200
| -3% | -$12.4K | 0.03% | 145 |
|
|
2021
Q4 | $456K | Sell |
6,400
-435
| -6% | -$31K | 0.03% | 142 |
|
|
2021
Q3 | $512K | Sell |
6,835
-325
| -5% | -$24.3K | 0.04% | 139 |
|
|
2021
Q2 | $553K | Sell |
7,160
-100
| -1% | -$7.72K | 0.04% | 146 |
|
|
2021
Q1 | $536K | Sell |
7,260
-200
| -3% | -$14.8K | 0.04% | 139 |
|
|
2020
Q4 | $523K | Sell |
7,460
-1,405
| -16% | -$98.5K | 0.04% | 152 |
|
|
2020
Q3 | $502K | Sell |
8,865
-3,050
| -26% | -$173K | 0.04% | 142 |
|
|
2020
Q2 | $694K | Sell |
11,915
-140
| -1% | -$8.15K | 0.06% | 124 |
|
|
2020
Q1 | $560K | Sell |
12,055
-3,050
| -20% | -$142K | 0.06% | 124 |
|
|
2019
Q4 | $844K | Sell |
15,105
-590
| -4% | -$33K | 0.08% | 128 |
|
|
2019
Q3 | $743K | Buy |
15,695
+6,495
| +71% | +$307K | 0.08% | 125 |
|
|
2019
Q2 | $492K | Buy |
9,200
+4,250
| +86% | +$227K | 0.05% | 141 |
|
|
2019
Q1 | $273K | Hold |
4,950
| – | – | 0.03% | 159 |
|
|
2018
Q4 | $233K | Buy |
+4,950
| New | +$233K | 0.03% | 156 |
|